[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Biosimilar Drug Market Research Report 2018

March 2018 | 98 pages | ID: CA20265F8C9QEN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Biosimilar Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Biosimilar Drug development status and future trend in China, focuses on top players in China, also splits Biosimilar Drug by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • CP Guojian Pharma
  • Biotech Pharma
  • Celgen Pharma
  • Henlius
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
  • Injection
  • Tablets
  • Others
On the basis of the end users/application, this report covers
  • Ankylosing Spondylitis
  • Tumor
  • Rheumatoid Arthrtis
  • Cardiovascular
If you have any special requirements, please let us know and we will offer you the report as you want.
China Biosimilar Drug Market Research Report 2018

1 BIOSIMILAR DRUG OVERVIEW

1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug by Product Category
  1.2.1 China Biosimilar Drug Sales (K MT) Comparison by Type (2013-2025)
  1.2.2 China Biosimilar Drug Sales (K MT) Market Share by Type in 2017
  1.2.3 Injection
  1.2.4 Tablets
  1.2.5 Others
1.3 China Biosimilar Drug Market by Application/End Users
  1.3.1 China Biosimilar Drug Sales (K MT) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Ankylosing Spondylitis
  1.3.3 Tumor
  1.3.4 Rheumatoid Arthrtis
  1.3.5 Cardiovascular
1.4 China Biosimilar Drug Market by Region
  1.4.1 China Biosimilar Drug Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Biosimilar Drug Status and Prospect (2013-2025)
  1.4.3 East China Biosimilar Drug Status and Prospect (2013-2025)
  1.4.4 Southwest China Biosimilar Drug Status and Prospect (2013-2025)
  1.4.5 Northeast China Biosimilar Drug Status and Prospect (2013-2025)
  1.4.6 North China Biosimilar Drug Status and Prospect (2013-2025)
  1.4.7 Central China Biosimilar Drug Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Biosimilar Drug (2013-2025)
  1.5.1 China Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2025)
  1.5.2 China Biosimilar Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA BIOSIMILAR DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Biosimilar Drug Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Biosimilar Drug Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Biosimilar Drug Average Price (USD/MT) by Players/Manufacturers (2013-2018)
2.4 China Biosimilar Drug Market Competitive Situation and Trends
  2.4.1 China Biosimilar Drug Market Concentration Rate
  2.4.2 China Biosimilar Drug Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Biosimilar Drug Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA BIOSIMILAR DRUG SALES AND REVENUE BY REGION (2013-2018)

3.1 China Biosimilar Drug Sales (K MT) and Market Share by Region (2013-2018)
3.2 China Biosimilar Drug Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Biosimilar Drug Price (USD/MT) by Regions (2013-2018)

4 CHINA BIOSIMILAR DRUG SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Biosimilar Drug Sales (K MT) and Market Share by Type/ Product Category (2013-2018)
4.2 China Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Biosimilar Drug Price (USD/MT) by Type (2013-2018)
4.4 China Biosimilar Drug Sales Growth Rate (%) by Type (2013-2018)

5 CHINA BIOSIMILAR DRUG SALES BY APPLICATION (2013-2018)

5.1 China Biosimilar Drug Sales (K MT) and Market Share by Application (2013-2018)
5.2 China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA BIOSIMILAR DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 CP Guojian Pharma
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biosimilar Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 CP Guojian Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Biotech Pharma
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biosimilar Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biotech Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Celgen Pharma
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biosimilar Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Celgen Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Henlius
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biosimilar Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Henlius Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview


7 BIOSIMILAR DRUG MANUFACTURING COST ANALYSIS

7.1 Biosimilar Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biosimilar Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biosimilar Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA BIOSIMILAR DRUG MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Biosimilar Drug Sales (K MT), Revenue (Million USD) Forecast (2018-2025)
11.2 China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
11.3 China Biosimilar Drug Sales (K MT) Forecast by Application (2018-2025)
11.4 China Biosimilar Drug Sales (K MT) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Biosimilar Drug Sales (K MT) and Revenue (Million USD) Market Split by Product Type
Table Biosimilar Drug Sales (K MT) by Application (2013-2025)
Figure Product Picture of Biosimilar Drug
Table China Biosimilar Drug Sales (K MT) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Biosimilar Drug Sales Volume Market Share by Types in 2017
Figure Injection Product Picture
Figure Tablets Product Picture
Figure Others Product Picture
Figure China Biosimilar Drug Sales (K MT) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Biosimilar Drug by Application in 2017
Figure Ankylosing Spondylitis Examples
Table Key Downstream Customer in Ankylosing Spondylitis
Figure Tumor Examples
Table Key Downstream Customer in Tumor
Figure Rheumatoid Arthrtis Examples
Table Key Downstream Customer in Rheumatoid Arthrtis
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure South China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Biosimilar Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Biosimilar Drug Sales of Key Players/Manufacturers (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Biosimilar Drug Sales Share (%) by Players/Manufacturers
Figure 2017 China Biosimilar Drug Sales Share (%) by Players/Manufacturers
Table China Biosimilar Drug Revenue by Players/Manufacturers (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Biosimilar Drug Revenue Market Share (%) by Players/Manufacturers
Table China Market Biosimilar Drug Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Biosimilar Drug Average Price of Key Players/Manufacturers in 2017
Figure China Biosimilar Drug Market Share of Top 3 Players/Manufacturers
Figure China Biosimilar Drug Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Biosimilar Drug Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Biosimilar Drug Product Category
Table China Biosimilar Drug Sales (K MT) by Regions (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Sales Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Regions in 2017
Table China Biosimilar Drug Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Revenue Market Share (%) by Regions (2013-2018)
Figure China Biosimilar Drug Revenue Market Share (%) by Regions in 2017
Table China Biosimilar Drug Price (USD/MT) by Regions (2013-2018)
Table China Biosimilar Drug Sales (K MT) by Type (2013-2018)
Table China Biosimilar Drug Sales Share (%) by Type (2013-2018)
Figure China Biosimilar Drug Sales Share (%) by Type (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Type in 2017
Table China Biosimilar Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Biosimilar Drug Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type (2013-2018)
Figure Revenue Market Share of Biosimilar Drug by Type in 2017
Table China Biosimilar Drug Price (USD/MT) by Types (2013-2018)
Figure China Biosimilar Drug Sales Growth Rate (%) by Type (2013-2018)
Table China Biosimilar Drug Sales (K MT) by Applications (2013-2018)
Table China Biosimilar Drug Sales Market Share (%) by Applications (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Application (2013-2018)
Figure China Biosimilar Drug Sales Market Share (%) by Application in 2017
Table China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
Figure China Biosimilar Drug Sales Growth Rate (%) by Application (2013-2018)
Table CP Guojian Pharma Biosimilar Drug Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure CP Guojian Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Biotech Pharma Biosimilar Drug Basic Information List
Table Biotech Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Biotech Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Biotech Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Celgen Pharma Biosimilar Drug Basic Information List
Table Celgen Pharma Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Celgen Pharma Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Celgen Pharma Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Henlius Biosimilar Drug Basic Information List
Table Henlius Biosimilar Drug Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (%)(2013-2018)
Figure Henlius Biosimilar Drug Sales (K MT) and Growth Rate (%)(2013-2018)
Figure Henlius Biosimilar Drug Sales Market Share (%) in China (2013-2018)
Figure Henlius Biosimilar Drug Revenue Market Share (%) in China (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Players/Manufacturers in 2017
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure China Biosimilar Drug Sales (K MT) and Growth Rate (%) Forecast (2018-2025)
Figure China Biosimilar Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Biosimilar Drug Price (USD/MT) Trend Forecast (2018-2025)
Table China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
Figure China Biosimilar Drug Sales (K MT) Forecast by Type (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Type in 2025
Table China Biosimilar Drug Sales (K MT) Forecast by Application (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Biosimilar Drug Sales Volume Market Share Forecast by Application in 2025
Table China Biosimilar Drug Sales (K MT) Forecast by Regions (2018-2025)
Table China Biosimilar Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Biosimilar Drug Sales Volume Share Forecast by Regions (2018-2025)
Figure China Biosimilar Drug Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories